Still, our study suggests that PTX3 and HMGB1 expressed on MPO+MPs might be used as promising biomarkers reflecting inflammation and disease activity in AAV patients. This evidence concerns the gene MPO and anti-neutrophil cytoplasmic antibody-associated vasculitis.